Cargando…
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors
CAR T cell therapy remains ineffective in solid tumors, due largely to poor infiltration and T cell suppression at the tumor site. T regulatory (T(reg)) cells suppress the immune response via inhibitory factors such as transforming growth factor–β (TGF-β). T(reg) cells expressing the C-C chemokine r...
Autores principales: | Cadilha, Bruno L., Benmebarek, Mohamed-Reda, Dorman, Klara, Oner, Arman, Lorenzini, Theo, Obeck, Hannah, Vänttinen, Mira, Di Pilato, Mauro, Pruessmann, Jasper N., Stoiber, Stefan, Huynh, Duc, Märkl, Florian, Seifert, Matthias, Manske, Katrin, Suarez-Gosalvez, Javier, Zeng, Yi, Lesch, Stefanie, Karches, Clara H., Heise, Constanze, Gottschlich, Adrian, Thomas, Moritz, Marr, Carsten, Zhang, Jin, Pandey, Dharmendra, Feuchtinger, Tobias, Subklewe, Marion, Mempel, Thorsten R., Endres, Stefan, Kobold, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189699/ https://www.ncbi.nlm.nih.gov/pubmed/34108220 http://dx.doi.org/10.1126/sciadv.abi5781 |
Ejemplares similares
-
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2019) -
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
por: Stoiber, Stefan, et al.
Publicado: (2019) -
Impact of the selective A2(A)R and A2(B)R dual antagonist AB928/etrumadenant on CAR T cell function
por: Seifert, Matthias, et al.
Publicado: (2022) -
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy
por: Lorenzini, Theo, et al.
Publicado: (2023) -
A modular and controllable T cell therapy platform for acute myeloid leukemia
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2021)